Autopsy report · NCT05427630
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Cause of deathFunding or business
“Inadequate funding”
Life of this trial
- Registered 8 months before it started.
- Suspended: paused, and may or may not restart.
- 20 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- University of California, San Diego
- Sponsor type
- University, hospital or other
- Conditions
- Migraine; Cannabis; THC
- Interventions
- THC ~2.5%; THC ~5%; THC ~10%; Sham Cannabis
- Participants
- 20 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- PROtecting Maternal Brains From Injury and Stroke
“Lack of funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.